Details
Stereochemistry | RACEMIC |
Molecular Formula | C12H18N4O2 |
Molecular Weight | 250.2969 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(C)CN1C2=C(N=C(C)N2)C(=O)N(C)C1=O
InChI
InChIKey=MTBUJUHRXVGLEF-UHFFFAOYSA-N
InChI=1S/C12H18N4O2/c1-5-7(2)6-16-10-9(13-8(3)14-10)11(17)15(4)12(16)18/h7H,5-6H2,1-4H3,(H,13,14)
Molecular Formula | C12H18N4O2 |
Molecular Weight | 250.2969 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/6388955
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6388955
Verofylline is a derivative of naturally occurring purine base xanthine. Verofylline acts as a long-acting bronchodilator. In animals, the drug has stronger bronchodilator activity but weaker chronotropic and inotropic activity than theophylline. A clinical trial of verofylline in patients with asthma has shown only weak activity.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:00:01 GMT 2023
by
admin
on
Fri Dec 15 19:00:01 GMT 2023
|
Record UNII |
1J8O1GT31U
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C319
Created by
admin on Fri Dec 15 19:00:01 GMT 2023 , Edited by admin on Fri Dec 15 19:00:01 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C96193
Created by
admin on Fri Dec 15 19:00:01 GMT 2023 , Edited by admin on Fri Dec 15 19:00:01 GMT 2023
|
PRIMARY | |||
|
SUB00042MIG
Created by
admin on Fri Dec 15 19:00:01 GMT 2023 , Edited by admin on Fri Dec 15 19:00:01 GMT 2023
|
PRIMARY | |||
|
100000079101
Created by
admin on Fri Dec 15 19:00:01 GMT 2023 , Edited by admin on Fri Dec 15 19:00:01 GMT 2023
|
PRIMARY | |||
|
DTXSID30867209
Created by
admin on Fri Dec 15 19:00:01 GMT 2023 , Edited by admin on Fri Dec 15 19:00:01 GMT 2023
|
PRIMARY | |||
|
47845
Created by
admin on Fri Dec 15 19:00:01 GMT 2023 , Edited by admin on Fri Dec 15 19:00:01 GMT 2023
|
PRIMARY | |||
|
1J8O1GT31U
Created by
admin on Fri Dec 15 19:00:01 GMT 2023 , Edited by admin on Fri Dec 15 19:00:01 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105599
Created by
admin on Fri Dec 15 19:00:01 GMT 2023 , Edited by admin on Fri Dec 15 19:00:01 GMT 2023
|
PRIMARY | |||
|
66172-75-6
Created by
admin on Fri Dec 15 19:00:01 GMT 2023 , Edited by admin on Fri Dec 15 19:00:01 GMT 2023
|
PRIMARY | |||
|
4760
Created by
admin on Fri Dec 15 19:00:01 GMT 2023 , Edited by admin on Fri Dec 15 19:00:01 GMT 2023
|
PRIMARY | |||
|
C030126
Created by
admin on Fri Dec 15 19:00:01 GMT 2023 , Edited by admin on Fri Dec 15 19:00:01 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |